Also trades as: 0GX2.L (LSE) · $vol 0M
NRO.PA PAR
Neurones S.A.
1W: -4.9%
1M: -3.0%
3M: -2.6%
YTD: -10.1%
1Y: -12.3%
3Y: -1.5%
5Y: +10.9%
€35.20 ($39.56)
-0.65 (-1.81%)
Weekly Expected Move ±4.0%
€32
€34
€35
€37
€38
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$84M
+17.1% ▲
5Y CAGR: +6.6%
Capital Expenditures
$12M
+33.1% ▲
5Y CAGR: +8.8%
Free Cash Flow
$72M
+33.7% ▲
5Y CAGR: +6.2%
Dividends Paid
$29M
-9.3% ▼
Buybacks
$28K
+0.0% ▲
Net Change in Cash
$31M
+30.2% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $31M | $38M | $44M | $59M | $63M |
| Depreciation & Amort. | $15M | $15M | $15M | $17M | $18M |
| Stock-Based Comp. | $2M | $3M | $4M | $6M | $5M |
| Change in Working Capital | $13M | $2M | -$13M | $1M | $8M |
| Other Non-Cash Items | $7M | $8M | $4M | -$10M | -$10M |
| Operating Cash Flow | $67M | $64M | $55M | $72M | $84M |
| — Investing Activities — | |||||
| Capital Expenditures | -$7M | -$7M | -$11M | -$18M | -$12M |
| Acquisitions (Net) | $86K | -$4M | -$809K | -$4M | -$7M |
| Investment Purchases | -$1M | -$1M | -$2M | -$2M | -$2M |
| Investment Sales | $384K | $569K | $808K | $2M | $461K |
| Other Investing | $0 | $156K | $56K | $77K | $260K |
| Investing Cash Flow | -$8M | -$11M | -$12M | -$22M | -$20M |
| — Financing Activities — | |||||
| Net Debt Issuance | $68K | -$193K | -$248K | $4M | $834K |
| Stock Repurchased | -$1M | $0 | -$107K | $0 | -$28K |
| Dividends Paid | -$5M | -$48M | -$24M | -$27M | -$29M |
| Other Financing | -$5M | -$7M | -$11M | -$4M | -$6M |
| Financing Cash Flow | -$11M | -$55M | -$36M | -$27M | -$34M |
| Net Change in Cash | $48M | -$1M | $7M | $23M | $31M |
| Cash End of Period | $266M | $265M | $272M | $295M | $326M |
| Free Cash Flow | $62M | $58M | $44M | $54M | $72M |